Table 2 Zones of inhibition (mm) produced by each of the eight EPS for secondary screening
| Â | Methicillin-resistant Staphylococcus aureus | Enterococcus faecalis | Streptococcus pneumoniae | Streptococcus agalactiae | Pseudomonas aeruginosa | Acinetobacter sp. | Campylobacter jejuni |
|---|---|---|---|---|---|---|---|
EPS extract | |||||||
  E5 | 7.8 ± 0.1 | 0.0 | 0.0 | 0.0 | 7.4 ± 0.4 | 0.0 | 0.0 |
  E15 | 10.0 ± 0.1 | 11.3 ± 0.2 | 9.4 ± 0.2 | 7.4 ± 0.3 | 0.0 | 0.0 | 9.5 ± 0.1 |
  E16 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
  E18 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
  E19 | 0.0 | 0.0 | 7.5 ± 0.1 | 0.0 | 7.4 ± 0.2 | 0.0 | 0.0 |
  E20 | 0.0 | 0.0 | 8.8 ± 0.1 | 0.0 | 7.4 ± 0.3 | 0.0 | 8.3 ± 0.1 |
  E26 | 7.5 ± 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 7.6 ± 0.3 | 0.0 |
  E37 | 8.8 ± 0.2 | 0.0 | 7.8 ± 0.1 | 0.0 | 7.6 ± 0.1 | 0.0 | 7.5 ± 0.2 |